L. Luzi et al., Postabsorptive muscle protein metabolism in type 1 diabetic patients afterpancreas transplantation, ACT DIABETO, 37(4), 2000, pp. 219-224
Insulin was shown to induce protein anabolism in vivo mainly by inhibiting
proteolysis. Heterotopic pancreas transplantation in type 1 diabetes mellit
us is characterized by peripheral hyperinsulinemia due to systemic rather t
han portal insulin delivery. Therefore, we studied the postabsorptive muscl
e protein metabolism in type 1 diabetic patients with or without pancreas t
ransplantation. The forearm balance technique was performed in 9 type 1 dia
betic patients on exogenous insulin treatment, in 4 type 1 diabetic patient
s following successful pancreas transplantation and in 6 healthy volunteers
. Labelled leucine and phenylalanine were infused to quantify whole-body an
d muscle protein synthesis, respec tively. In the postabsorptive state, who
le-body protein synthesis (leucine kinetics) was similar in pancreas-transp
lanted patients and controls. In contrast, muscle protein synthesis tended
to be less negative in pancreas-transplanted patients with respect to type
1 diabetic patients and healthy volunteers. The present data suggest that r
ecipients with peripheral insulin delivery and chronic hyperinsulinemia are
characterized by a preferential stimulation of protein synthesis in muscle
rather than in the splanchnic district. When insulin was infused acutely,
while maintaining euglycemia, the whole-body and muscle protein synthesis r
ates were approximately halved in type 1 diabetic patients with and without
pancreas transplantation. We conclude that pancreas transplantation is abl
e to normalize basal and insulin-stimulated protein metabolism. Chronic hyp
erinsulinemia counteract steroid-induced protein degradation by means of a
mild, but persistent stimulation of muscle protein synthesis.